menu
    • menu

    Company profile for BioVie

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BioVie Inc. (ticker symbol: BIVI) is a clinical-stage company developing innovative drug therapies for liver disease. Our new drug candidate, BIV201 (continuous infusion terlipressin), is currently being tested in a mid-stage (Phase 2a) clinical trial for ascites due to advanced liver cirrhosis. It has an Orphan Drug designation for the treatment of ascites, FDA Fast Track status, and US patent protection. BIV201 also has an O...
    BioVie Inc. (ticker symbol: BIVI) is a clinical-stage company developing innovative drug therapies for liver disease. Our new drug candidate, BIV201 (continuous infusion terlipressin), is currently being tested in a mid-stage (Phase 2a) clinical trial for ascites due to advanced liver cirrhosis. It has an Orphan Drug designation for the treatment of ascites, FDA Fast Track status, and US patent protection. BIV201 also has an Orphan Drug designation for the treatment of hepatorenal syndrome (HRS).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BioVieUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2120 Colorado Ave., #230 Santa Monica, CA 90404
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biovieinc.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/biovie-inc.
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/biovie_inc?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biovie Hosts Live Investor Webinar On December 9
    Biovie Hosts Live Investor Webinar On December 9

    19 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/19/3190852/0/en/Join-Biovie-s-Exclusive-Live-Investor-Webinar-and-Q-A-Session-on-December-9.html

    GLOBENEWSWIRE
    19 Nov 2025
    Share Share
    Biovie To Host Live Investor Webinar And Q&a On Oct. 8
    Biovie To Host Live Investor Webinar And Q&a On Oct. 8

    26 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/26/3156974/0/en/BioVie-to-Host-Live-Investor-Webinar-and-Q-A-on-Oct-8.html

    GLOBENEWSWIRE
    26 Sep 2025
    Share Share
    BioVie Explores Bezisterim for COVID Neurological Symptoms Trial
    BioVie Explores Bezisterim for COVID Neurological Symptoms Trial

    13 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/13/3132962/0/en/BioVie-Highlighted-ADDRESS-LC-Phase-2-Trial-Design-Exploring-Bezisterim-for-the-Treatment-of-Neurological-Symptoms-of-Long-COVID-at-Keystone-Symposia-on-Long-COVID-and-Other-Post-A.html

    GLOBENEWSWIRE
    13 Aug 2025
    Share Share
    BioVie Closes $12 Million Public Offering
    BioVie Closes $12 Million Public Offering

    11 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/11/3131256/0/en/BioVie-Inc-Announces-Closing-of-12-Million-Public-Offering.html

    GLOBENEWSWIRE
    11 Aug 2025
    Share Share
    BioVie Announces Pricing of $12 Million Public Offering
    BioVie Announces Pricing of $12 Million Public Offering

    07 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/08/3129900/0/en/BioVie-Inc-Announces-Pricing-of-12-Million-Public-Offering.html

    GLOBENEWSWIRE
    07 Aug 2025
    Share Share
    BioVie Reveals Bezisterim's Potential Age Deceleration Advantage
    BioVie Reveals Bezisterim's Potential Age Deceleration Advantage

    24 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/24/3120972/0/en/BioVie-Presented-Data-Highlighting-that-Patients-Treated-with-Bezisterim-Potentially-Experienced-an-Age-Deceleration-Advantage-Compared-to-Placebo-on-10-Different-Biological-Clocks.html

    GLOBENEWSWIRE
    24 Jul 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search